Markets.com Logo

CTXDF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.1315$
  • Previous Close
    0.1253$
  • 52 Week Change
    0.11$
  • Day Range
    0.01$
  • 52 Week High/Low
    0.0597$ - 0.1655$
  • Dividend Per Share
    --
  • Market cap
    16 600 K$
  • EPS
    -0.0019
  • Beta
    0.157
  • Volume
    --

About

CTXDF.US refers to the stock of Crypto Technologies & Development Corp. traded on the OTC (Over-the-Counter) market in the United States. This symbol is used to identify and track the company's shares as they are bought and sold outside of the major stock exchanges like the NYSE or Nasdaq. It's important to note that OTC stocks often carry higher risks due to less stringent listing requirements and potentially lower liquidity.
Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Gold price (XAU/USD) rises to new ATH: Will gold keep going up in 2026?

Ghko B|--
Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Best EV stocks to buy in 2026: Rivian stock, Lucid stock, NIO, TSLA stock

Ghko B|--
Trending AI stocks analysis: Could Nebius (NBIS) stock doble in 2026?

Trending AI stocks analysis: Could Nebius (NBIS) stock doble in 2026?

Ghko B|--
Stellar XLM price prediction: Could XLM/USD reach $1 in 2026?

Stellar XLM price prediction: Could XLM/USD reach $1 in 2026?

Ghko B|--
NVIDIA soars 39% in 2025: Will NVDA stock surge to $250 in 2026?

NVIDIA soars 39% in 2025: Will NVDA stock surge to $250 in 2026?

Ghko B|--
Tesla stock crashes 4% on Q4 results: Is NASDAQ: TSLA stock overvalued?

Tesla stock crashes 4% on Q4 results: Is NASDAQ: TSLA stock overvalued?

Ghko B|--
CoreWeave Stock Analysis: Is CoreWeave (CRWV) stock a good buy in 2026?

CoreWeave Stock Analysis: Is CoreWeave (CRWV) stock a good buy in 2026?

Ghko B|--

Factors

CTXDF.US, representing Cardiol Therapeutics, is influenced by several factors: Clinical Trial Results: Positive trial outcomes often drive stock price increases; negative results can cause declines. Regulatory Approvals: FDA or other agency approvals for Cardiol's drugs substantially boost the stock. Financial Performance: Revenue, expenses, and profitability directly impact investor confidence. Market Sentiment: Overall investor optimism or pessimism towards biotech stocks can affect CTXDF.US. Competition: Actions and advancements by competitors in the cardiovascular space influence market share projections. Partnerships: Collaborations with pharmaceutical companies often signal credibility and future revenue. Economic Conditions: Broader economic factors like interest rates and inflation can affect investment in growth stocks. Management Decisions: Strategic choices made by Cardiol's leadership impact investor perception.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

What is the Russell 2000: How to start trading the Russell 2000 Index?

What is the Russell 2000: How to start trading the Russell 2000 Index?

Ghko B|--
Candlestick Patterns Explained: How to Use Morning Star Candlestick Pattern?

Candlestick Patterns Explained: How to Use Morning Star Candlestick Pattern?

Ghko B|--
What Is a Full Body Candle: How to Read Candlestick Charts?

What Is a Full Body Candle: How to Read Candlestick Charts?

Ghko B|--